| |
|
| |
Clin Pharmacol Ther, Vol. 81, No. 1. (January 2007), pp. 122-125.
|
| |
The Pharmacogenomics Journal, Vol. 5 (2005), pp. 75-80.
|
| |
In Pharmacogenomics and Pharmacy Practice in Pharmacogenomics: Social, Ethical and (2003)
|
| |
Personalized Medicine, Vol. 2, No. 1. (2005), pp. 29-35.
|
| |
Pharmacogenomics, Vol. 4, No. 2. (March 2003), pp. 107-112.
|
| |
Am J Pharmacogenomics, Vol. 3, No. 6. (2003), pp. 385-392.
|
| |
Personalized Medicine, Vol. 2, No. 1. (2005), pp. 29-35.
|
| |
Yale J Health Policy Law Ethics, Vol. 1 (2001), pp. 33-75.
|
| |
The pharmacogenomics journal, Vol. 1, No. 3. (2001), pp. 167-170.
by T. E. Klein, J. T. Chang, M. K. Cho, et al.K. L. Easton, R. Fergerson, M. Hewett, Z. Lin, Y. Liu, S. Liu, D. E. Oliver, D. L. Rubin, F. Shafa, J. M. Stuart, R. B. Altman
|
| |
Genet Med, Vol. 5, No. 5. (t 2003), pp. 393-399.
|
| |
Genet Med, Vol. 5, No. 5. (t 2003), pp. 385-392.
|
| |
Nat Rev Genet, Vol. 2, No. 3. (March 2001), pp. 228-231.
|
| |
Health Aff (Millwood) (11 October 2005)
|
| |
Am Univ Law Rev, Vol. 55, No. 2. (December 2005), pp. 395-452.
|
| |
Health Commun, Vol. 19, No. 1. (2006), pp. 61-73.
|
| |
Journal of Health Communication, Vol. 9, No. 6., 541.
|
| |
Am J Public Health, Vol. 95, No. 12. (December 2005), pp. 2133-2138.
|